APA (7th ed.) Citation

Zhai, H., Zhang, N., Mo, D., & Qin, T. (2023). CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer. Journal of international medical research, 51(8), 3000605231171762. https://doi.org/10.1177/03000605231171762

Chicago Style (17th ed.) Citation

Zhai, Hongyan, Na Zhang, Dan Mo, and Tingting Qin. "CCL20 Is a Potential Therapeutic Target Associated with Immune Infiltration in Breast Cancer." Journal of International Medical Research 51, no. 8 (2023): 3000605231171762. https://doi.org/10.1177/03000605231171762.

MLA (9th ed.) Citation

Zhai, Hongyan, et al. "CCL20 Is a Potential Therapeutic Target Associated with Immune Infiltration in Breast Cancer." Journal of International Medical Research, vol. 51, no. 8, 2023, p. 3000605231171762, https://doi.org/10.1177/03000605231171762.